Evidence map›Paper›PMID 35600046›Full record

ArticleJournal of immunology research2022

L-Borneol 7-O-[

Ziyi Tong, Gaowen Li, Chengxiao Su, Liyan Zhou, Ling Zhang, Qun Chen, Qing Xia

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of immunology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ziyi TongDepartment of Pharmacology, Ningbo College of Health Sciences, Ningbo, Zhejiang, China.ORCID https://orcid.org/0000-0003-2694-4387
Gaowen LiDepartment of Pharmacology, Ningbo College of Health Sciences, Ningbo, Zhejiang, China.ORCID https://orcid.org/0000-0002-8691-4270
Chengxiao SuDepartment of Pharmacology, Ningbo College of Health Sciences, Ningbo, Zhejiang, China.ORCID https://orcid.org/0000-0002-2253-6581
Liyan ZhouDepartment of Pharmacology, Ningbo College of Health Sciences, Ningbo, Zhejiang, China.ORCID https://orcid.org/0000-0003-3017-424X
Ling ZhangDepartment of Pharmacology, Ningbo College of Health Sciences, Ningbo, Zhejiang, China.ORCID https://orcid.org/0000-0002-4907-8648
Qun ChenDepartment of Pharmacology, Ningbo College of Health Sciences, Ningbo, Zhejiang, China.ORCID https://orcid.org/0000-0001-5338-187X
Qing XiaDepartment of Pharmacology, Ningbo College of Health Sciences, Ningbo, Zhejiang, China.ORCID https://orcid.org/0000-0002-6651-0586
Ningbo College of Health Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia/reperfusion (I/R) is a primary cause of morbidity and mortality in acute myocardial infarction (AMI). L-Borneol 7-O-[

Indexed as

Myocardial InfarctionMyocardial Reperfusion InjuryAnimalsApoptosisCamphanesHypoxiaMyocytes, CardiacPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRatsSignal TransductionTOR Serine-Threonine KinasesCamphanesisoborneolmTOR protein, ratPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine Kinases

Identifiers

PMID35600046
PMCPMC9119761
OpenAlexW4280644481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.